Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP2 | O95551 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 8/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 8/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.57 |
| ▸ | MAPT | P10636 | 7/20 | 0.57 |
| ▸ | HPGD | P15428 | 3/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | ALPL | P05186 | 1/20 | 0.39 |
| ▸ | ALPI | P09923 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL6656501 | 1.00 | TDP2 (0.69) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL6658960 | 0.99 | TDP2 (0.70) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL6658957 | 0.99 | TDP2 (0.70) | TDP2MEN1KMT2AALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL6655370 | 0.88 | MAPT (0.57) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL13528778 | 0.87 | MAPT (0.58) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL6655240 | 0.87 | MAPT (0.58) | TDP2MEN1KMT2AALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL6656769 | 0.86 | ALDH1A1 (0.65) | TDP2MEN1KMT2AALDH1A1MAPT | |
| Ammonia Solution, Strong SCHEMBL6656768 | 0.86 | ALDH1A1 (0.65) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL14196851 | 0.86 | MEN1 (0.62) | TDP2MEN1KMT2AALDH1A1MAPT | |
| SCHEMBL5706408 | 0.86 | MEN1 (0.74) | TDP2MEN1KMT2AALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1041953-B1 | AGENTS AND METHOD FOR PRODUCING TEMPORARY COLORATIONS OF KERATIN FIBERS | WELLA AG (DE) | 2004-07-07 | — | — | EP | claimed |
| US-6494923-B2 | POLYMETHINE DYES, ESPECIALLY PYRAZOLONE DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-17 | — | — | US | claimed |
| US-20020010969-A1 | AGENTS AND METHOD FOR PRODUCING TEMPORARY COLORATIONS OF KERATIN FIBERS | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2002-01-31 | — | — | US | claimed |
| US-6494923-B2 | POLYMETHINE DYES, ESPECIALLY PYRAZOLONE DYES | WELLA AKTIENGESELLSCHAFT (DE) | 2002-12-17 | — | — | US | disclosed |
| US-20020010969-A1 | AGENTS AND METHOD FOR PRODUCING TEMPORARY COLORATIONS OF KERATIN FIBERS | HFC PRESTIGE INTERNATIONAL HOLDING SWITZERLAND S.A.R.L (CH) | 2002-01-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020010969-A1 | AGENTS AND METHOD FOR PRODUCING TEMPORARY COLORATIONS OF KERATIN FIBERS | KRT18, DSG1, SPTAN1 | TDP2 3371/4885MEN1 2475/4885KMT2A 607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.